BioSpace News Archive

Genetown

GI Dynamics Announces AUD $6.9m Private Placement to be Completed in Two Tranches

GI Dynamics, Inc. is pleased to announce it has received binding commitments for a private placement of 347,222,250 CHESS Depositary Interests (CDIs) of the Company

September 19, 2018
·
9 min read
Business

Celltrion Signs ‘Incubation’ Agreement with Emory University for Development of New Drugs for Atherosclerosis

Research on new mechanisms to prevent ischemic heart disease and stroke, the leading causes of death in the world

September 19, 2018
·
3 min read
Drug Development

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment for Patients with NSCLC at Annual Meeting of the Chinese Society of Clinical Oncology

Innovent Biologics (Innovent), presented clinical trial data on cohort D of sintilimab clinical studies at the 2018 Annual Meeting of Chinese Society of Clinical Oncology (CSCO).

September 19, 2018
·
5 min read
Viking Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

Viking Therapeutics, Inc. today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

September 19, 2018
·
5 min read
BioMidwest

Company Profile for QST Consultations, Ltd

QST Consultations is a full service clinical research organization dedicated to providing specialized clinical research support for the pharmaceutical and medical device industries since its founding in 1974 (incorporation in 1985).

September 19, 2018
·
1 min read
Business

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

ohnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 16th, to review third-quarter results. Joseph J. Wolk, Executive Vice President, Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host the call.

September 19, 2018
·
2 min read
BioMidwest

Patterson Companies Declares Regular Quarterly Cash Dividend

On September 18, 2018, the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, October 26, 2018, to shareholders of record as of the close of business on October 12, 2018.

September 19, 2018
·
1 min read
Lone Star Bio

New Study Demonstrates High Efficacy of HumanN’s BeetElite for HIIT Training

A new study on BeetElite, an endurance superfood from HumanN, has found that taking the product allows cycling participants to recover quicker between high intensity training intervals, and work out 17.9% longer.

September 19, 2018
·
5 min read
Business

Natural Alternatives International, Inc. Announces Fiscal 2018 and Q4 Results

Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $2.9 million, or $0.41 per diluted share, on net sales of $39.2 million for the quarter ended June 30, 2018.

September 19, 2018
·
13 min read
joimax® Introduces Intracs® em Electromagnetic Navigation System

joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic spinal surgery, introduces another minimally invasive device, Intracs® em Electromagnetic Navigation System, at two global spine events:

September 19, 2018
·
3 min read